Oncology Medical News about Castlemans disease

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

HHV8-positive, HIV-negative multicentric Castlemans disease: early and sustained complete remission with rituximab therapy without reactivation of Kaposi sarcoma
International Journal of Hematology, 09/24/09

Nicoli P et al. – No reactivation of the Kaposi sarcoma found in a lymph node of one of the patients was observed. The report, along with additional data present in the literature, suggests that rituximab may be an appropriate and safe first–line therapy for HIV–negative, HHV8–positive MCD.

<< Previous
Sequential adenovirus infection of type 14 hemorrhagic cystitis...

Next >>
Intra- and interobserver reproducibility of interpretation of...